Study of Out of Specification for Tisagenlecleucel
NCT04094311
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
B-cell Acute Lymphoblastic Leukemia
Diffuse Large B-cell Lymphoma
Interventions
BIOLOGICAL:
CTL019
Sponsor
Novartis Pharmaceuticals